Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 25 2026

Full Issue

Chris Klomp's Bid To Become HHS Deputy Secretary Advances To Full Senate Vote

Meanwhile, Senate Health Committee Chairman Bill Cassidy, R-Louisiana, pressed FDA nominee Dr. Heidi Overton about her vaccine stance. “This committee needs to know whether you will be radically honest, whether you will use your authority to stand up for sound science and protect children’s health,� Cassidy said. A vote on Overton's nomination has not been scheduled.

A key Senate committee on Thursday approved the nomination of top federal health official Chris Klomp to be deputy secretary of the Department of Health and Human Services, clearing the way for him to be confirmed by the full Senate. (Cirruzzo and Wilkerson, 9/24)

President Donald Trump’s pick to lead the Food and Drug Administration voiced support for the safety of long-established vaccines at a hearing Thursday, even as senators questioned her about the White House’s efforts to upend childhood immunizations. Dr. Heidi Overton is currently serving as a White House adviser and has worked on a series of Trump health initiatives, including an executive order last month that called for splitting up and spacing out decades-old childhood vaccinations. Overton, a physician, stood beside Trump in the Oval Office when he falsely remarked that the combined measles, mumps and rubella vaccine could be “quite lethal.� (Perrone, 9/24)

Health Secretary Robert F. Kennedy Jr.’s future aides keep repudiating his views about vaccines. Since senators balked at confirming surgeon general nominee Casey Means, a parade of Health Department nominees have endorsed vaccination as the best way to prevent infectious diseases and rejected Kennedy’s supposition that vaccines cause autism. (Paun, 9/24)

Other health news from Capitol Hill —

In one Virginia race and others, Democrats are highlighting the rising costs of health care and possible closures of facilities, putting Republicans on defense. (Schneider, 9/24)

As Democrats release a flurry of midterm ads portraying GOP cuts to Medicaid as a threat to rural healthcare, Republicans have countered with ads claiming Democratic candidates in Texas and Pennsylvania would put dozens of rural hospitals out of business by creating a public health insurance option. But the ads cite an industry-backed study whose assumptions don’t apply to all public option proposals. (Cuno-Booth, 9/23)

Ñî¹óåú´«Ã½Ò•îl Health News: Ñî¹óåú´«Ã½Ò•îl Health News’ ‘What The Health?’: Healthcare A Vague But Potent Issue For Election 2026

Healthcare, in particular its rising costs, is a key issue for voters in both parties this fall. But lawmakers are offering a variety of remedies on the campaign trail, suggesting that neither party has an agreed-upon approach. Meanwhile, the Trump administration has apparently backed off a plan — for now — to create a political board to review scientific grant awards from the National Institutes of Health. (Rovner, 9/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, September 25
  • Thursday, September 24
  • Wednesday, September 23
  • Tuesday, September 22
  • Monday, September 21
  • Friday, September 18
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF